Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China flag China · Delayed Price · Currency is CNY
5.98
-0.48 (-7.43%)
Nov 17, 2026, 3:00 PM CST

Jiangsu Nanfang Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-105.79-101.71-190.67-147.42-14.65-22.76
Depreciation & Amortization
-0--54.6741.6129.04
Other Amortization
---2.312.71.59
Loss (Gain) From Sale of Assets
---2.9-0.02-0.05
Asset Writedown & Restructuring Costs
---35.550.052.48
Loss (Gain) From Sale of Investments
----9.29-8.59-7.65
Provision & Write-off of Bad Debts
---29.894.434.58
Other Operating Activities
132.28122.9246.6754.3725.3134.59
Change in Accounts Receivable
----23.24-33.77-16.84
Change in Inventory
----0.38-76.84-113.14
Change in Accounts Payable
---17.74105.622.79
Change in Other Net Operating Assets
-----10.97
Operating Cash Flow
26.4921.195615.5131.28-84.25
Operating Cash Flow Growth
-65.31%-62.16%261.05%-50.41%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.68-3.26-5.11-66.16-146.16-211.75
Sale of Property, Plant & Equipment
0.01-0.040.940.070.09
Investment in Securities
3.33.3----20
Other Investing Activities
8.257.546.8548.8796.76.28
Investing Cash Flow
2.877.571.79-16.35-181.42-225.38

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-525.14466.5602.53980.94792.25
Total Debt Issued
511.98525.14466.5602.53980.94792.25
Long-Term Debt Repaid
--557.79-507.6-638.61-836.8-619.06
Lease Payments
-0.43-0.43-0.43-0.43-0.43-0.43
Total Debt Repaid
-516.79-557.79-507.6-638.61-836.8-619.06
Net Debt Issued (Repaid)
-4.81-32.64-41.1-36.08144.14173.18
Repurchase of Common Stock
------1.41
Common Dividends Paid
-21.99-5.17-6.6-21.63-18.6-47.09
Other Financing Activities
14.98--18.6---
Financing Cash Flow
-11.82-37.82-66.31-57.71125.53124.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.040.541.39-0.18-0.85-3.76
Net Cash Flow
15.5-8.52-7.13-58.74-25.45-188.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
17.8117.9250.89-50.65-114.88-296.01
Free Cash Flow Growth
-81.06%-64.78%----
Free Cash Flow Margin
3.18%2.98%8.44%-8.44%-21.07%-56.12%
Free Cash Flow Per Share
0.060.060.18-0.17-0.39-1.04
Levered Free Cash Flow
35.985.7-44.75-30.85-126.45-232.72
Unlevered Free Cash Flow
38.0319.28-28.23-16.36-113.83-225.34
Free Cash Flow After Leases
17.3817.4950.45-51.08-115.31-296.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
5.647.54-3.811.03-49.622.61
Change in Working Capital
----7.48-19.56-126.07